Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus

Yu-huang ZHENG; Yan HE; Xu YANG; Guo-zhong GONG; Hua-ying ZHOU; Chun-ying ZHANG; Wen ZHOU; Li HUANG; Pei-pei DING; Hui LI.
Chinese Journal of Hepatology ; (12): 741-744, 2005.
Artículo en Zh | WPRIM | ID: wpr-276365

Documentos relacionados

  1. Validation of a computerized decision support system to review pharmacotherapy treatment: scheduling guidelines.
  2. The biochemistry of disease: desperately seeking syzygy.
  3. Aortite chez une patiente recevant une chimiothérapie.
  4. Evaluating automated entity extraction with respect to drug and non-drug treatment strategies.
  5. RNA-based therapeutics: ready for delivery?
  6. Anything you can do I can do better.
  7. Communication in Drug Development: "Translating" Scientific Discovery.
  8. [Dissonance in addictology - The missed encounter between Laszlo Levendel and Thomas Szasz].
  9. [Health-Related Quality of Life in the Context of Early Benefit Assessment of Drugs According to § 35a of the German Social Code Book V: A Challenging Endpoint for all the Involved Stakeholders].
  10. Prediction of drug's Anatomical Therapeutic Chemical (ATC) code by integrating drug-domain network.